Kazia Therapeutics Limited

Industry

  • Pharmaceuticals
    • Vaccines
  • Biotechnology

Other Names/Subsidiaries

  • CanTx (joint venture)
  • Glioblast
  • Novogen
  • Triaxial Pharmaceuticals
See more in Biomedtracker

Latest on Kazia Therapeutics Limited

Scrip

Deal Watch: A Closer Look At Boehringer Ingelheim’s Partnering Strategy

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim GmbH is closely

Scrip

Asia Deal Watch: Nippon Shinyaku Takes On Intractable Rare Disease With MiNA

 
• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, Lisa Takagi, and Anju Ghangurde

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. MiNA Will Provide RNAa Candidates

Scrip

Deal Watch: Gilead Acquires Xilio’s IL-12 Activating Candidate

 
• By Joseph Haas and Alaric DeArment

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug

Scrip

Tech Transfer Roundup: Tiba And CEPI Strategize Together On ‘Disease X’

 
• By Joseph Haas

Tiba, CEPI Strive To Plan Ahead For Next Pandemic Tiba Biotech LLC and CEPI (Coalition for Epidemic Preparedness Innovations) said on 12 January that they will partner to evaluate the Cambridge, M